Effect of an Olive Oil-Based Lipid Emulsion Compared with a Soybean Oil-Based Lipid Emulsion on Liver Chemistry and Bile Acid Composition in Preterm Infants Receiving Parenteral Nutrition: A Double-Blind, Randomized Trial

Journal of Parenteral and Enteral Nutrition

Volumn 40, Issue 6, 2016, Pages 842-850

  Wang, Ying ^a,b   Zhou, Ke Jun ^b,c   Tang, Qing Ya ^a,b   Hong, Li ^a   Feng, Yi ^a   Lu, Li Na ^a   Wang, Wei Ping ^a   Cai, Wei ^a,b,c,d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition   (China)

^c Shanghai Institute of Pediatric Research   (China)

^d XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

bile acid; lipid emulsion; liver chemistry; olive oil; parenteral nutrition

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; LIPID EMULSION; OLIVE OIL; SOYBEAN OIL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN; CHEMISTRY; CHOLESTASIS; COMPARATIVE STUDY; LIVER; LIVER DISEASE; METABOLISM; PROCEDURES;

BILE ACIDS AND SALTS; CHOLESTASIS; DOUBLE-BLIND METHOD; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LIVER; LIVER DISEASES; MALE; OLIVE OIL; PARENTERAL NUTRITION; SOYBEAN OIL;

EID: 84979030950     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607114566853     Document Type: Article

References (36)

1. Kelly DA,. Intestinal failure-associated liver disease: what do we know today. Gastroenterology. 2006; 130: S70-S77.
2. Nehra D, Fallon EM, Puder M,. The prevention and treatment of intestinal failure-associated liver disease in neonates and children. Surg Clin North Am. 2011; 91: 543-563.
3. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK,. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol. 2007; 27: 284-290.
4. Diamond IR, de Silva N, Pencharz PB, Kim JH, Wales PW,. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg. 2007; 42: 806-811.
5. Cavicchi M, Beau P, Crenn P, Degott C, Messing B,. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132: 525-532.
6. Colomb V, Goulet O, De Potter S, Ricour C,. Liver disease associated with long-term parenteral nutrition in children. Transplant Proc. 1994; 26: 1467.
7. Goulet O, Joly F, Corriol O, Colomb-Jung V,. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2009; 14: 256-261.
8. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C,. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000; 24: 345-350.
9. Marik PE,. Maximizing efficacy from parenteral nutrition in critical care: appropriate patient populations, supplemental parenteral nutrition, glucose control, parenteral glutamine, and alternative fat sources. Curr Gastroenterol Rep. 2007; 9: 345-353.
10. Diamond IR, Sterescu A, Pencharz PB, Wales PW,. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int. 2008; 24: 773-778.
11. Guglielmi FW, Regano N, Mazzuoli S, et al. Cholestasis induced by total parenteral nutrition. Clin Liver Dis. 2008; 12: 97-110.
12. Cober MP, Killu G, Brattain A, Welch KB, Kunisaki SM, Teitelbaum DH,. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr. 2012; 160: 421-427.
13. Cowles RA, Ventura KA, Martinez M, et al. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg. 2010; 45: 84-87.
14. Jensen AR, Goldin AB, Koopmeiners JS, Stevens J, Waldhausen JH, Kim SS,. The association of cyclic parenteral nutrition and decreased incidence of cholestatic liver disease in patients with gastroschisis. J Pediatr Surg. 2009; 44: 183-189.
15. Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS,. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome. Nutr Clin Pract. 2010; 25: 199-204.
16. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009; 250: 395-402.
17. Xu Z, Harvey KA, Pavlina T, et al. Steroidal compounds in commercial parenteral lipid emulsions. Nutrients. 2012; 4: 904-921.
18. Deshpande GC, Simmer K, Mori T, Croft K,. Parenteral lipid emulsions based on olive oil compared with soybean oil in preterm (<28 weeks' gestation) neonates: a randomised controlled trial. J Pediatr Gastroenterol Nutr. 2009; 49: 619-625.
19. Webb AN, Hardy P, Peterkin M, et al. Tolerability and safety of olive oil-based lipid emulsion in critically ill neonates: a blinded randomized trial. Nutrition. 2008; 24: 1057-1064.
20. Working Group of Pediatrics, Chinese Society of Parenteral and Enteral Nutrition, Working Group of Neonatology, Chinese Society of Pediatrics, Working Group of Neonatal Surgery, Chinese Society of Pediatric Surgery. CSPEN guidelines for nutrition support in neonates. Asia Pac J Clin Nutr. 2013; 22: 655-663.
21. Janzen N, Sander S, Terhardt M, et al. Rapid quantification of conjugated and unconjugated bile acids and C27 precursors in dried blood spots and small volumes of serum. J Lipid Res. 2010; 51: 1591-1598.
22. Goulet O, de Potter S, Antébi H, et al. Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr. 1999; 70: 338-345.
23. Munck A,. Comparison of fatty acid status in TPN-dependent children receiving two lipid emulsions with different essential fatty acid (EFA) content [abstract]. Clin Nutr. 1993; 12 (suppl 2): 17.
24. Kumpf VJ,. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006; 21: 279-290.
25. Wispe JR, Bell EF, Roberts RJ,. Assessment of lipid peroxidation in newborn infants and rabbits by measurements of expired ethane and pentane: influence of parenteral lipid infusion. Pediatr Res. 1985; 19: 374-379.
26. Tomsits E, Rischak K, Szollar L,. Long-term effects of unsaturated fatty acid dominance on the release of free radicals in the rat. Pediatr Res. 1994; 36: 278-282.
27. Hong L, Wang X, Wu J, Cai W,. Mitochondria-initiated apoptosis triggered by oxidative injury play a role in total parenteral nutrition-associated liver dysfunction in infant rabbit model. J Pediatr Surg. 2009; 44: 1712-1718.
28. Llop JM, Virgili N, Moreno-Villares JM, et al. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition. 2008; 24: 1145-1152.
29. Iyer KR, Spitz L, Clayton P,. BAPS prize lecture: new insight into mechanisms of parenteral nutrition-associated cholestasis: role of plant sterols. British Association of Paediatric Surgeons. J Pediatr Surg. 1998; 33: 1-6.
30. Bindl L, Lutjohann D, Buderus S, Lentze MJ, Bergmann KV,. High plasma levels of phytosterols in patients on parenteral nutrition: a marker of liver dysfunction. J Pediatr Gastroenterol Nutr. 2000; 31: 313-316.
31. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ,. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology. 1993; 105: 1806-1813.
32. Vlaardingerbroek H, Ng K, Stoll B, et al. New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. J Lipid Res. 2014; 55: 466-477.
33. Moss RL, Das JB, Raffensperger JG,. Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg. 1993; 28: 1270-1274.
34. Child P, Kuksis A,. Investigation of the role of micellar phospholipid in the preferential uptake of cholesterol over sitosterol by dispersed rat jejunal villus cells. Biochem Cell Biol. 1986; 64: 847-853.
35. D'Apolito O, Pianese P, Salvia G, et al. Plasma levels of conjugated bile acids in newborns after a short period of parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010; 34: 538-541.
36. Chiang JY,. Bile acids: regulation of synthesis. J Lipid Res. 2009; 50; 1955-1966.